Track SQZ Biotechnologies Company — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

SQZ Biotechnologies Company SQZ · Stock Open SQZ Biotechnologies Company in new tab

0.4350 USD
Loading chart...

DCF valuation

Model fair value for SQZ Biotechnologies Company (SQZ)
Result
Sign in to run the valuation for SQZ.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

SQZ Biotechnologies Company Logo SQZ Biotechnologies Company Analysis (SQZ)

United States Health Care Official Website Stock

Is SQZ Biotechnologies Company a good investment? SQZ Biotechnologies Company (SQZ) is currently trading at 0.4350 USD.

Investor FAQ

Does SQZ Biotechnologies Company pay a dividend?

No, it does not currently pay a dividend.

What asset class is SQZ Biotechnologies Company?

SQZ Biotechnologies Company is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Exchange Ticker
NYQ (United States) SQZ
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
July 7, 2023 1:10
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion